Alexandria Real Estate Equities
ARE
#2299
Rank
S$10.78 B
Marketcap
S$61.89
Share price
1.09%
Change (1 day)
-27.68%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -S$0.8 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are S$2.85 Billion. In 2025 the company made an earning of -S$1.27 Billion a decrease over its 2024 earnings that were of S$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.8 Billion-37.46%
2025 -S$1.27 Billion-242.13%
2024 S$0.89 B96.11%
2023 S$0.45 B-53.56%
2022 S$0.97 B-3.96%
2021 S$1.01 B-20.26%
2020 S$1.27 B72.88%
2019 S$0.73 B3.11%
2018 S$0.71 B73.54%
2017 S$0.41 B464.88%
2016 S$73.12 M-77.32%
2015 S$0.32 B36.31%
2014 S$0.23 B-10.81%
2013 S$0.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.55 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.82 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.62 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.53 B-1,688.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.48 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.27 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.11 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA